Skip to main navigation Skip to search Skip to main content

UB CAT: Assessment of the Effect of TVB-628 (OPLS) to Reduce Immunogenicity for Selected Therapeutic Proteins

Project: Research

Project Details

StatusFinished
Effective start/end date02/1/22 → 06/30/22

Funding

  • Truvai Biosciences Limited Liability Corporation: $49,551.00